ResearcherHainan General HospitalNo recent work listed
Jinfang Zheng
Matched on ORCID iD 0000-0002-1098-8636; OpenAlex author ID A5064175547. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 2 papers
Papers 4
- LncRNA NORAD regulates the mechanism of the miR-532-3p/Nectin-4 axis in pancreatic cancer cell proliferation and angiogenesis. Last author DOI 10.1093/toxres/tfad026↗
- Hsa_circ_0084003 modulates glycolysis and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma through targeting hsa-miR-143-3p/DNMT3A axis. Last author DOI 10.1093/toxres/tfad032↗
- Circular RNA Fibroblast Growth Factor Receptor 1 Promotes Pancreatic Cancer Progression by Targeting MicroRNA-532-3p/PIK3CB Axis. Last author DOI 10.1097/mpa.0000000000002119↗
- Development and clinical validation of A Novel 9-gene prognostic biomarkers based on multi-omics in pancreatic adenocarcinoma Last author DOI 10.21203/rs.3.rs-49603/v1↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kaiqiong Wang · 2 shared papers, 2023 · strength 0.53
- Paper LncRNA NORAD regulates the mechanism of the miR-532-3p/Nectin-4 axis in pancreatic cancer cell proliferation and angiog… DOI 10.1093/toxres/tfad026↗
- Paper Hsa_circ_0084003 modulates glycolysis and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma through… DOI 10.1093/toxres/tfad032↗
- Kai-Qiong Wang · 1 shared paper, 2022 · strength 0.19
- Yu Wang · 1 shared paper, 2020 · strength 0.11
- Dafeng Xu · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.